Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2017 | (b) 2018 | (c) 2019 | (d) 2020 | (e) 2021 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2017 | (b) 2018 | (c) 2019 | (d) 2020 | (e) 2021 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2017 | (b) 2018 | (c) 2019 | (d) 2020 | (e) 2021 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 15,975,015 | 17,418,939 | 17,909,110 | 27,777,561 | 22,194,016 | 101,274,641 |
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | 699,890 | 1,485,340 | 681,274 | 1,167,985 | 1,353,589 | 5,388,078 |
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | 16,674,905 | 18,904,279 | 18,590,384 | 28,945,546 | 23,547,605 | 106,662,719 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | 0 | |||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | 1,231 | 369,536 | 370,767 | |||
| c | Add lines 7a and 7b.. | 1,231 | 369,536 | 370,767 | |||
| 8 | Public support. (Subtract line 7c from line 6.) | 106,291,952 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2017 | (b) 2018 | (c) 2019 | (d) 2020 | (e) 2021 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 16,674,905 | 18,904,279 | 18,590,384 | 28,945,546 | 23,547,605 | 106,662,719 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 2,432 | 3,126 | 33,820 | 16,792 | 11,574 | 67,744 |
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | 2,432 | 3,126 | 33,820 | 16,792 | 11,574 | 67,744 |
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 16,677,337 | 18,907,405 | 18,624,204 | 28,962,338 | 23,559,179 | 106,730,463 |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2021 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2021 |
(iii) Distributable Amount for 2021 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2021 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2021 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2021: | ||||
| a From 2016....... | ||||
| b From 2017....... | ||||
| c From 2018....... | ||||
| d From 2019....... | ||||
| e From 2020....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2021 distributable amount | ||||
|
i
Carryover from 2016 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2021 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2021 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2021, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2021. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2022. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2017..... | ||||
| b Excess from 2018..... | ||||
| c Excess from 2019..... | ||||
| d Excess from 2020..... | ||||
| e Excess from 2021..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| 3. SHIN-NY ON FHIR DOH PUBLIC HEALTH USE CASE | AS THE SHIN-NY CONTINUES TO BUILD A ROBUST FHIR FRAMEWORK FOR THE SHIN-NY IN SUPPORT OF A PUBLIC HEALTH FUTURE STATE, THE SFY 2020-21 INTEROPERABILITY AND INNOVATION PROJECT LEVERAGES THE EXISTING FHIR FOUNDATION INFRASTRUCTURE CREATED DURING THE SFY 2019-20 I&I PROGRAM. THE SHIN-NY ON FHIR DOH PUBLIC HEALTH USE CASE PROJECT WILL DEVELOP APPROPRIATE SECURITY AND TRANSPORT MODELS FOR A TRUSTED SYSTEM TO SYSTEM BATCH FHIR REQUEST AND RESPONSE. THIS PROJECT SUPPORTS THE DEVELOPMENT OF AN ENTERPRISE-WIDE FHIR-ENABLED NETWORK CAPABLE OF SUPPORTING PUBLIC HEALTH USE CASES THAT WILL BENEFIT NEW YORK STATE AND IMPACT BROAD POPULATIONS. THROUGH THE SHIN-NY ON FHIR DOH PUBLIC HEALTH USE CASE PROJECT, THE SHINNY ENTERPRISE WILL BE ABLE TO SUPPORT DOH USERS TO QUERY, VIEW, AND CAPTURE NEEDED DISCRETE OR BULK DATA FOR PUBLIC HEALTH PURPOSES, BEGINNING WITH COVID-19 AND MOVING ON TO OTHERS, TO THE EXTENT POSSIBLE DURING THE PROJECT PERIOD. ADDITIONALLY, THIS PROJECT WILL LAY THE FOUNDATION FOR THE SHIN-NY TO PROVIDE ADDITIONAL PUBLIC HEALTH BENEFIT, STATEWIDE AND LOCALLY. QES WILL WORK WITH NYEC TO DEFINE AND DEVELOP REQUIREMENTS TO SUPPORT THE PUBLIC HEALTH USE CASES AND IMPLEMENT SYSTEM TO SYSTEM FHIR BATCH REQUESTS FOR A DEFINED PATIENT COHORT. QES WILL DOCUMENT READINESS AND PLANNING TO UPGRADE TO FHIR R4, ACTIVELY PARTICIPATE IN ALL PROJECT DISCOVERY AND PLANNING SESSIONS, PARTICIPATE IN FHIR TRAINING, COMPLETE HL7 FHIR (R4) PROFICIENCY CERTIFICATION, AND DESIGN, DEVELOP, AND IMPLEMENT THE PUBLIC HEALTH USE CASES, BEGINNING WITH COVID-19 AND MOVING ON TO OTHERS, AS POSSIBLE DURING THE PROJECT PERIOD. DURING THE YEAR ENDED DECEMBER 31, 2021, THE COMPANY RECORDED $239,999 IN REVENUE IN CONNECTION WITH THIS PROGRAM. 4. HOSPITAL EVENT NOTIFICATIONS REQUIREMENT AND STANDARDIZATION IN THE CMS INTEROPERABILITY AND PATIENT ACCESS FINAL RULE A CONDITION OF PARTICIPATION EXISTS FOR MEDICARE AND MEDICAID APPLICABLE HOSPITALS TO SEND ELECTRONIC EVENT NOTIFICATIONS TO A PATIENT'S ESTABLISHED PRIMARY CARE PRACTITIONER, LONG-TERM CARE PROVIDER, OR ANY OTHER PRACTITIONER IDENTIFIED BY THE PATIENT. HOSPITALS IN HEALTHIX NETWORK ARE A SIGNIFICANTLY IMPORTANT SET OF STAKEHOLDERS; ACCORDINGLY, THROUGH THIS PROJECT HEALTHIX PARTICIPATED IN VARIOUS ACTIVITIES TO ENSURE IT CAN SUPPORT HOSPITALS IN MEETING THIS CMS REQUIREMENT, ACTING AS AN INTERMEDIARY TO THE HOSPITALS IN SENDING ALERTS. HEALTHIX PARTICIPATED IN ANALYSIS AND DATA COLLECTION IN THE AREAS OF DATA CONTRIBUTION FROM HOSPITALS, NEW TRIGGER EVENTS, TECHNICAL ISSUES, CROSS QE ALERTS, AND ALERTS BASED ON TREATING RELATIONSHIP. HEALTHIX IDENTIFIED GAPS IN THE CURRENT STATE OF EVENT NOTIFICATIONS IN MEETING THE HOSPITAL REQUIREMENTS AND PLAN FOR GAP CLOSURE. ADDITIONALLY, HEALTHIX HELPED WITH THE DEVELOPMENT AND DOCUMENTATION OF STATEWIDE PROCEDURES TO SUPPORT THE DEMONSTRATION OF HOSPITAL COMPLIANCE WITH THE FEDERAL RULE. ACTIVITY - MILESTONE #1: WORKGROUP PARTICIPATION QE WILL ESTABLISH WORKGROUP DESIGNATED REPRESENTATIVE AND DELEGATE(S) TO ATTEND AND ACTIVELY PARTICIPATE IN ALL WORKGROUP MEETINGS RELATED TO THE PROJECT. THE WORKGROUP WILL ACHIEVE THE FOLLOWING: - METHODS, NORMALIZATION, AND LEVEL-SETTING FOR ANALYSIS OF EVENT NOTIFICATIONS DATA COLLECTION - ANALYSIS OF GAPS IN MINIMUM DATA ELEMENTS RECEIVED FROM HOSPITALS ANALYSIS OF TRANSFER FROM ED TO INPATIENT ALERTS - REVIEWING AND PROVIDING FEEDBACK ON THE IMPLEMENTATION OF OBSERVATION STATUS ALERTS, CROSS QE ALERTS, AND ALERTS BASED ON TREATING RELATIONSHIP FOR THE MINIMUM DATA ELEMENTS - REVIEWING AND PROVIDING FEEDBACK ON STATEWIDE CONSISTENT PROCESSES FOR SENDING INFORMATION TO PROVIDERS THAT ARE NOT PARTICIPANTS OF THE SHIN-NY APPROPRIATE QE SUBJECT MATTER EXPERTS WILL PARTICIPATE IN ANY ON-DEMAND ACTIVITIES FOR THE PURPOSE OF THE PROJECT. DELIVERABLE 1.1 - QE WILL IDENTIFY DESIGNATED REPRESENTATIVE AND DELEGATES; QE'S REPRESENTATION WILL ATTEND AND PARTICIPATE IN ALL PROJECT DISCOVERY MEETINGS AND FOLLOW-UP ACTIVITIES CONVENED BY NYEC THROUGHOUT THE PROJECT PERIOD. DELIVERABLE 1.2 - QE WILL PROVIDE DOCUMENTATION AND WRITTEN RESPONSES/COMMENTS TO NYEC REQUESTS FOR FEEDBACK, AS NEEDED. ACTIVITY - MILESTONE #4: GAP CLOSURE QES WILL ANALYZE, PLAN FOR AND IMPLEMENT GAP CLOSURE OF ANY GAPS IDENTIFIED IN THE HOSPITAL EVENT NOTIFICATIONS CURRENTLY BEING SENT TO THE QE IN SUPPORT OF THE CMS MINIMUM DATA ELEMENTS AND ALL REQUIRED TRIGGER EVENTS. DELIVERABLE 4.1 - QE WILL CLOSE ALL GAPS IN THE HOSPITAL EVENT NOTIFICATIONS CURRENTLY BEING SENT TO THE QE IN SUPPORT OF THE CMS MINIMUM DATA ELEMENTS AND ALL REQUIRED TRIGGER EVENTS AS EVIDENCED BY SUBMISSION OF A GAP CLOSURE NARRATIVE WORKBOOK. NYEC WILL REQUEST SAMPLE ADT MESSAGES TO VALIDATE GAP CLOSURE. ACTIVITY - MILESTONE #5: DEVELOPMENT AND/OR DOCUMENTATION OF PROCESSES TO SUPPORT HOSPITALS IN MEETING REQUIREMENTS HOSPITALS ARE REQUIRED TO DEMONSTRATE THAT ITS SYSTEM SENDS NOTIFICATIONS TO THE APPROPRIATE RECIPIENTS. TO SUPPORT HOSPITALS IN THE CMS SURVEY AND CERTIFICATION PROCESS, QES WILL DEVELOP DOCUMENTATION OF PROCESSES AND PROCEDURES RELATED TO RECEIVING AND SENDING EVENT NOTIFICATIONS AS AN INTERMEDIARY TO THE HOSPITAL. DELIVERABLE 5.1 QE WILL PROVIDE DOCUMENTATION OF PROCESSES TO RECEIVE INFORMATION FROM HOSPITALS TO ADVISE THE QE OF ANY PROVIDERS PATIENTS WISH TO HAVE ALERTS SENT TO. DELIVERABLE 5.2 QE WILL IDENTIFY AND IMPLEMENT STATEWIDE PROCESSES FOR SENDING INFORMATION TO PROVIDERS THAT ARE NOT PARTICIPANTS OF THE SHIN-NY. ACTIVITY - MILESTONE #6: ALERT STANDARDIZATION VIA WORKGROUP, QES WILL WORK TOWARD STANDARDIZATION OF ALERTS FOR STAKEHOLDERS SPANNING MULTIPLE QES: 1. PROVIDE INSIGHT INTO ANALYSIS OF DATA COLLECTION AND STATEWIDE METHODS FOR STANDARDIZATION 2. SUPPORT CONSENSUS BUILDING ON STATEWIDE STANDARDIZATION APPROACH PROVIDE INPUT AND FEEDBACK ON BEHALF OF QE HEALTH PLAN PARTICIPANTS DELIVERABLE 6.1 QE WILL PROVIDE DOCUMENTATION AND WRITTEN RESPONSES/COMMENTS TO NYEC REQUESTS FOR FEEDBACK, AS NEEDED. DURING THE YEAR ENDED DECEMBER 31, 2021, THE COMPANY RECORDED $261,890 IN REVENUE IN CONNECTION WITH THIS PROGRAM. 5. DATA SEGMENTATION THE DATA SEGMENTATION PROJECT WAS INTENDED TO PROVIDE INFORMATION ABOUT HEALTHIX CAPABILITIES FOR IDENTIFYING SENSITIVE HEALTH INFORMATION IN THE CURRENT ENVIRONMENTS. THE INFORMATION GATHERED DURING THIS PROJECT SERVED AS A BASELINE IN ORDER TO INFORM A DATA SEGMENTATION ROADMAP FOR THE SHIN-NY ENTERPRISE REGARDLESS OF WHAT CONSENT MODEL MAY BE ADOPTED IN NY STATE IN THE FUTURE. CURRENTLY THE CATEGORIES OF SENSITIVE HEALTH INFORMATION GOVERNED BY SPECIAL PROTECTIONS AS PER FEDERAL AND STATE LAW AND THE SHIN-NY PRIVACY AND SECURITY POLICIES AND PROCEDURES FOR QES AND THEIR PARTICIPANTS INCLUDES MENTAL HEALTH, ALCOHOL AND SUBSTANCE ABUSE, REPRODUCTIVE HEALTH, SEXUALLY-TRANSMITTED DISEASE, HIV/AIDS, AND GENETIC TESTING INFORMATION. FOR OTHER SENSITIVE HEALTH INFORMATION THAT HAS BEEN ADDRESSED VIA USE OF, FOR EXAMPLE, RE-DISCLOSURE WARNINGS WAS NOTED IN THE ANALYSIS. DURING THE YEAR ENDED DECEMBER 31, 2021, THE COMPANY RECORDED $123,830 IN REVENUE IN CONNECTION WITH THIS PROGRAM. 6. HERDS AS PART OF THE PANDEMIC RESPONSE, HOSPITALS WERE ASKED TO PROVIDE INFORMATION ABOUT PATIENTS WITH COVID-19 HOSPITALIZATIONS AND FATALITIES WITHIN HEALTH EMERGENCY RESPONSE DATA SYSTEM (HERDS). THIS ANALYSIS WAS PERFORMED TO COMPARE SHIN-NY CLINICAL DATA SUBMISSIONS WITH HOSPITAL HERDS SURVEY DATA. DATA FROM FOUR DOMAINS WAS ANALYZED: CAPACITY, MORTALITY, COMORBIDITIES, AND DATA QUALITY OF SHIN-NY HEALTH RECORDS. HEALTHIX SHOWED THAT THEY HAD DATA AND COULD CALCULATE CAPACITY METRICS, BUT THE DATA SHOWED VARIANCE MOST COMMONLY AS OVER-REPORTING OF BED OCCUPANCY WHEN COMPARED TO SYSTEMS WITH SURVEY REPORTED DATA. THIS IS PRIMARILY DUE TO THE FACT THAT THE EXISTING INTERFACES WHICH TRANSMIT DATA FROM HOSPITALS TO THE SHIN-NY WERE NOT DESIGNED FOR THIS PARTICULAR USE CASE AND WHENEVER A NEW USE CASE IS PRESENTED, IT REQUIRES ADDITIONAL DEVELOPMENT TO MEET THE NEW SPECIFIC BUSINESS REQUIREMENTS. CONSEQUENTLY, IT WAS DETERMINED THAT WITHOUT SIGNIFICANT EFFORTS, THE SHINY-NY COULD NOT READILY AUGMENT THEIR EXISTING INTERFACES TO SUFFICIENTLY SUPPORT STATEWIDE CAPACITY REPORTING IN THE NEAR TERM. HOWEVER, THE SHIN-NY'S STRUCTURED DATA SHOWED CONFORMANCE TO STANDARDS AND WAS SEEN AS VIABLE FOR FURTHER FEASIBILITY TESTING. DURING THE YEAR ENDED DECEMBER 31, 2021, THE COMPANY RECORDED $186,514 IN REVENUE IN CONNECTION WITH THIS PROGRAM. |
| 7. UNIFORM ASSESSMENT SERVICES | THE SCOPE OF THIS PROJECT INCLUDED HEALTHIX SUBMITTING A ONE-TIME DATA EXTRACT FOR A PATIENT POPULATION THAT MEETS SPECIFICATION REQUIREMENTS AND HAS GONE THROUGH QUALITY ASSURANCE REVIEW BASED ON ACCURACY, CONFORMANCE, AND COMPLETION. NYEC THEN PROCESSED AND USED THE HEALTHIX SUBMISSION, WHICH WAS THEN PROVIDED BY NYEC TO NYS DOH (UAS), IN ACCORDANCE WITH SECURE FILE TRANSFER PROCESSES. HEALTHIX ACTIVELY PARTICIPATED IN PROJECT INITIATION MEETINGS, DATA EXTRACTION WITH SUPPORTING DOCUMENTATION FOR FEASIBILITY ANALYSIS AND EVALUATION. BELOW ARE THE MILESTONES AND DELIVERABLES: #1 - UNIFORM ASSESSMENT SYSTEM: QE STAFF WILL ACTIVELY PARTICIPATE AND ENGAGE IN KICK-OFF, QA AND EVALUATION MEETINGS (WILL BE SCHEDULED AFTER EXECUTION OF SOW). #2 - UNIFORM ASSESSMENT SYSTEM: DATA MAPPING/DEFINITIONS DOCUMENTS AND CODE SETS QE TO PROVIDE MAPPING/DEFINITIONS DOCUMENTS FOR FACILITIES AND ENCOUNTERS AND CODE SETS APPLICABLE TO THE DATA SET. #3 - UNIFORM ASSESSMENT SYSTEM: DATA SUBMISSION FOR FEASIBILITY STUDY TO SUPPORT UAS. ONE TIME FILE EXTRACT DELIVERED VIA SFTP. QE WILL SUBMIT DATA EXTRACT FOR PATIENT POPULATION THAT MEETS SPECIFICATION REQUIREMENTS AND HAS GONE THROUGH QUALITY ASSURANCE REVIEW BASED ON ACCURACY, CONFORMANCE, AND COMPLETION. #4 - UNIFORM ASSESSMENT SYSTEM: ANALYSIS QE TO PROVIDE A REPORT AS DEFINED IN PROJECT DOCUMENTATION DESCRIBING: NUMBER OF DATA SOURCES PER PATIENT AND FACILITY TYPE, DIAGNOSIS MEDICATION AND PROCEDURE PREVALENCE, NUMBER OF ENCOUNTERS PER PATIENT BY TYPE AND FACILITY. DURING THE YEAR ENDED DECEMBER 31, 2021, THE COMPANY RECORDED $50,000 IN REVENUE IN CONNECTION WITH THIS PROGRAM. |
| FORM 990, PART V, LINE 2A, NUMBER OF EMPLOYEES: | THE ORGANIZATION CHANGED PROFESSIONAL EMPLOYER ORGANIZATION (PEO) FROM ADP TOTALSOURCE TO PRESTIGE EMPLOYEE ADMINISTRATORS, LLC IN 2021 AND RECEIVED TWO SETS OF 2021 FORM W-2S. |
| FORM 990, PART VI, SECTION A, LINE 3 | HEALTHIX, INC. CHANGED PROFESSIONAL EMPLOYER ORGANIZATION (PEO) FROM ADP TOTALSOURCE TO PRESTIGE EMPLOYEE ADMINISTRATORS, LLC IN 2021 AND RECEIVED TWO SETS OF 2021 FORM W-2S. AS A PROFESSIONAL EMPLOYER ORGANIZATION, ADP TOTALSOURCE AND PRESTIGE EMPLOYEE ADMINISTRATORS, LLC PROVIDED PROFESSIONAL EMPLOYER SERVICES TO HEALTHIX, INC. IN THE PEO RELATIONSHIP THE PEO'S AND HEALTHIX, INC. SHARE CERTAIN RESPONSIBILITIES AND ALLOCATE OTHER EMPLOYER RESPONSIBILITIES BETWEEN EACH OTHER. THE PEO'S WERE PAID $77,832 DURING 2021 FOR SERVICES PROVIDED. |
| FORM 990, PART VI, SECTION A, LINE 6 | MEMBERSHIP: IN ORDER FOR AN ORGANIZATION OR INDIVIDUAL TO QUALIFY TO BE A PARTICIPANT IN THE REGIONAL HEALTH INFORMATION ORGANIZATION ("RHIO") OPERATED BY THE CORPORATION ("PARTICIPANT"), HE/SHE OR IT MUST ENTER INTO A RHIO SERVICES, PARTICIPATION OR SIMILAR AGREEMENT WITH THE CORPORATION (EACH, A "RHIO SERVICES AGREEMENT"), THE FORM OF WHICH HAS BEEN APPROVED BY THE BOARD OF DIRECTORS OF THE CORPORATION ("BOARD"), TO PARTICIPATE IN A CLINICAL INFORMATION DATA EXCHANGE PROGRAM WITH THE CORPORATION AND TO ACT AS A DATA SOURCE AND/OR DATA USER WITH RESPECT TO THE CORPORATION'S DATA EXCHANGE. A PARTICIPANT'S PARTICIPATION IN THE CORPORATION WILL TERMINATE IF THE RHIO SERVICES AGREEMENT IS TERMINATED FOR ANY REASON. |
| FORM 990, PART VI, SECTION B, LINE 11B | AFTER THE FORM IS PREPARED BY OUTSIDE ACCOUNTANTS, IT WILL FIRST BE REVIEWED BY THE SVP & CFO. IF THERE ARE ANY SUGGESTED CHANGES OR MODIFICATIONS, HE WILL COMMUNICATE DIRECTLY WITH THE OUTSIDE ACCOUNTANTS. ONCE THE SVP & CFO IS SATISFIED WITH THE 990, HE WILL PASS IT ON TO THE CEO FOR HIS REVIEW. ONCE THE CEO IS SATISFIED WITH THE 990, THE NEXT STEP IS TO PASS IT ON TO THE CHAIRMAN OF THE FINANCE COMMITTEE, WHO IS A MEMBER OF THE EXECUTIVE COMMITTEE AND THE BOARD OF DIRECTORS, FOR HIS REVIEW. ONCE THIS INDIVIDUAL IS SATISFIED WITH THE 990, IT WILL BE PASSED ON TO THE FULL EXECUTIVE COMMITTEE. THIS COMMITTEE IS A SUBSET OF THE FULL HEALTHIX, INC. BOARD AND IS CHARGED WITH MAKING MANY KEY DECISIONS AFFECTING THE COMPANY. IT IS THIS GROUP OF INDIVIDUALS THAT WILL AUTHORIZE THE FILING OF THE 990. ONCE THE EXECUTIVE COMMITTEE IS SATISFIED WITH THE 990 AND HAS AUTHORIZED ITS FILING, THE SVP & CFO WILL PROVIDE AN ELECTRONIC COPY TO THE FULL BOARD OF DIRECTORS PRIOR TO THE EXTENDED DUE DATE OF THE RETURN. THE BOARD WILL BE INFORMED THAT THE EXECUTIVE COMMITTEE HAS REVIEWED AND APPROVED THE 990. IF ANY BOARD MEMBER HAS ANY QUESTIONS OR CONCERNS THEY WILL BE INSTRUCTED TO CONTACT THE SVP & CFO, WHO WILL RESOLVE THEIR INQUIRIES PROMPTLY. |
| FORM 990, PART VI, SECTION B, LINE 12C | ALL DIRECTORS, OFFICERS, AND KEY PERSONS WILL, AT LEAST ANNUALLY THEREAFTER, FILE A WRITTEN CONFLICT OF INTEREST DISCLOSURE STATEMENT WITH HEALTHIX SENIOR DIRECTOR OF COMPLIANCE. HEALTHIX SENIOR DIRECTOR OF COMPLIANCE WILL PROVIDE COPIES OF ALL COMPLETED STATEMENTS TO THE CHAIR OF THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD FOR REVIEW. NEW DIRECTOR MUST FILE CONFLICT OF INTEREST PRIOR TO BEING ELECTED TO BECOME A HEALTHIX BOARD MEMBER. FOR DIRECTORS, THE CONFLICT OF INTEREST DISCLOSURE STATEMENT WILL SPECIFICALLY INCLUDE, AMONG OTHER DISCLOSABLE CONFLICTS OF INTEREST, A STATEMENT IDENTIFYING, TO THE BEST OF THE DIRECTOR'S KNOWLEDGE, ANY ENTITY OF WHICH HE OR SHE IS AN OFFICER, DIRECTOR, TRUSTEE, MEMBER, OWNER (EITHER AS A SOLE PROPRIETOR OR A PARTNER), OR EMPLOYEE AND WITH WHICH HEALTHIX HAS A RELATIONSHIP, AND ANY TRANSACTION IN WHICH HEALTHIX IS A PARTICIPANT AND IN WHICH THE DIRECTOR MIGHT HAVE A DISCLOSABLE CONFLICT OF INTEREST. ALL COMPLETED CONFLICT OF INTEREST DISCLOSURE STATEMENTS THAT RAISE AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST, OR THAT CREATE THE APPEARANCE OF AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST, WILL BE FORWARDED BY THE CHAIR OF THE AUDIT AND COMPLIANCE COMMITTEE TO THE AUDIT AND COMPLIANCE COMMITTEE FOR THEIR CONSIDERATION. THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD WILL CONDUCT A FULL REVIEW OF ALL MATTERS (E.G., CONTRACTS, TRANSACTIONS OR ARRANGEMENTS) FOR WHICH AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST OR THE APPEARANCE OF AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST HAS BEEN IDENTIFIED. IN SO DOING, THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD WILL: A. CONSIDER ALL RELEVANT FACTS AND CIRCUMSTANCES INVOLVED IN THE MATTER, AND IN PARTICULAR, WHAT IS FAIR, REASONABLE AND IN THE BEST INTERESTS OF HEALTHIX; B. EXCLUDE THE AFFECTED INDIVIDUAL(S) FROM BEING PRESENT AT OR PARTICIPATING IN, OR BEING COUNTED IN THE QUORUM FOR, THE DELIBERATIONS OR VOTING ON THE MATTER; C. PROHIBIT THE AFFECTED INDIVIDUAL(S) FROM ANY ATTEMPT TO INFLUENCE IMPROPERLY THE DELIBERATIONS OR VOTING ON THE MATTER; D. PERMIT THE AFFECTED INDIVIDUAL(S), UPON REQUEST OF THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD, TO PRESENT INFORMATION CONCERNING THE MATTER AT A MEETING PRIOR TO COMMENCEMENT OF DELIBERATIONS OR VOTING ON THE MATTER. E. NOT PERMIT ANY DIRECTOR TO VOTE OR BE COUNTED IN DETERMINING THE QUORUM FOR ANY VOTE, ON ANY TRANSACTION BETWEEN HEALTHIX AND ANOTHER CORPORATION, FIRM, ASSOCIATION OR OTHER ENTITY IN WHICH THE DIRECTOR IS AN OFFICER OR DIRECTOR OR HAS A DIRECT OR INDIRECT SUBSTANTIAL FINANCIAL INTEREST. THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD WILL MAKE A FINAL AND BINDING DETERMINATION AS TO WHETHER A CONFLICT OF INTEREST EXISTS OR MAY EXIST ON ANY MATTER IN WHICH THERE IS A DISCLOSABLE CONFLICT OF INTEREST, AND WHAT COURSE HEALTHIX WILL TAKE IN CONNECTION WITH THE MATTER. THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD WILL CONTEMPORANEOUSLY DOCUMENT IN WRITING IN APPROPRIATE MINUTES OF ANY MEETING AT WHICH THE MATTER IS DELIBERATED OR VOTED UPON ALL DELIBERATIONS AND DETERMINATIONS RELATING THERETO, INCLUDING, AT A MINIMUM: 1. THE NAMES AND POSITIONS OF PERSONS WHO DISCLOSED THAT THEY WERE RELATED PARTIES OR OTHERWISE WERE FOUND TO BE RELATED PARTIES OR TO HAVE A CONFLICT OF INTEREST, A DESCRIPTION OF THE NATURE OF THE RELATIONSHIP AND/OR SUBSTANTIAL FINANCIAL INTEREST WHICH GAVE RISE TO SUCH DISCLOSURE OR IDENTIFICATION, AND A DESCRIPTION OF THE CONTRACT, TRANSACTION OR ARRANGEMENT AT ISSUE; 2. THE NAMES OF THE AUDIT AND COMPLIANCE COMMITTEE WHO WERE PRESENT DURING THE TAKING OF THE ACTION TO DETERMINE WHETHER A CONFLICT OF INTERESTS WAS PRESENT, AND THE BASIS FOR THERE BEING A QUORUM FOR THE TAKING OF SUCH ACTION WITHOUT INCLUDING ANY RELATED PARTIES OR AFFECTED PARTIES; 3. THE STEPS TAKEN BY THE AUDIT AND COMPLIANCE COMMITTEE MEMBERS OF THE BOARD TO DETERMINE WHETHER A CONFLICT OF INTEREST WAS PRESENT; 4. THE AUDIT AND COMPLIANCE COMMITTEE BOARD MEMBER'S DECISION AS TO WHETHER A CONFLICT OF INTERESTS WAS PRESENT AND THE BASIS FOR SUCH DECISION; 5. THE AUDIT AND COMPLIANCE COMMITTEE BOARD MEMBER'S DECISION AS TO WHETHER TO PROCEED WITH THE MATTERS (INCLUDING, BUT NOT NECESSARILY LIMITED TO, WHETHER THE MATTER IS AS FAIR AND REASONABLE TO HEALTHIX AS WOULD OTHERWISE THEN BE OBTAINABLE BY HEALTHIX) AND THE NAMES OF THE PERSONS WHO VOTED TO APPROVE THE MATTER. |
| FORM 990, PART VI, SECTION B, LINE 15 | IN 2019, THE COMPANY ENGAGED THE SERVICES OF AN INDEPENDENT COMPENSATION CONSULTING COMPANY, THE "JER HR GROUP, LLC,", WHICH PERFORMED A FORMAL MARKET STUDY AND PROVIDED RANGES FOR SALARIES FOR EXECUTIVES, KEY EMPLOYEES AND FOR MOST POSITIONS IN THE COMPANY. THIS CONSULTANTS' REPORT WAS FINALIZED IN JANUARY 2020 & THE REPORT PROVIDED A VARIETY OF DATA, INCLUDING THE MEDIAN MARKET SALARY FOR MOST POSITIONS. THE CONSULTANTS' CONCLUSIONS WERE THAT SALARY ADJUSTMENT SHOULD BE MADE FOR EMPLOYEES WHOSE SALARY WAS 15% OR MORE BELOW THEIR MARKET MEDIAN. IN 2020, THE COMPANY MADE SALARY ADJUSTMENTS USING 12% AS AS OPPOSED TO 15%, (WITHIN A TOTAL % CAP FOR A SALARY INCREASE) AS MANAGEMENT FELT THAT THIS A BETTER CRITERIA. THIS COMPENSATION SURVEY WAS USED AGAIN IN 2021 TO SET COMPENSATION RANGES AS THE DATA WAS STILL CONSIDERED RELEVANT. GOALS WERE SET FOR ALL EMPLOYEES AT THE BEGINNING OF 2021, AND THEIR PERFORMANCE WAS MEASURED AGAINST GOALS AFTER 2021 CONCLUDED. BONUSES WHICH WERE ACCRUED AT 12/31/20 (BASED ON 2020 PERFORMANCE) WERE PAID IN 2021, AND THOSE WHICH WERE ACCRUED AT 12/31/21 (BASED ON 2021 PERFORMANCE) WERE PAID OUT IN 2022. THE INCENTIVE COMPENSATION (I.E. BONUS) AND MERIT INCREASE PROGRAMS WERE APPROVED BY THE EXECUTIVE COMMITTEE FOR BOTH 2021 & 2020, AND WERE ALSO DISTRIBUTED TO ALL EMPLOYEES. THE EXECUTIVE COMMITTEE HAS SERVED AS HEALTHIX COMPENSATION COMMITTEE. THE BY-LAWS CREATE A COMMITTEE OF THE BOARD WITH FULL POWERS OF THE BOARD TO REVIEW AND APPROVE THE COMPENSATION OF OFFICERS AND OTHER KEY EMPLOYEES. THE COMMITTEE, WHICH IS HEALTHIX'S EXECUTIVE COMMITTEE, CONSISTS OF TRUSTEES WHO HAVE NO CONNECTION TO HEALTHIX EXCEPT AS TRUSTEES AND THEY HAVE NO CONFLICTS AS TO MATTERS THEY CONSIDER. THE COMMITTEE MEETS SEVERAL TIMES A YEAR AS NEEDED, AND REVIEWS AND DETERMINES CEO COMPENSATION AS WELL AS THE OVERALL MERIT AND BONUS COMPENSATION FOR THE REST OF THE COMPANY. FOR PURPOSES OF THEIR REVIEW THE COMMITTEE CONSIDERS THE RECOMMENDATIONS OF THE CEO FOR ALL PERSONNEL OTHER THAN THE CEO. AS A RESULT OF THE INDEPENDENT SURVEY INDICATED ABOVE, THE COMMITTEE HAS LET THE CEO DETERMINE COMPENSATION ADJUSTMENTS FOR OTHER OFFICERS AND KEY PERSONNEL, BASED ON THAT SURVEY'S RESULTS. THIS PROCESS WAS LAST UNDERTAKEN IN 2021. THE EXECUTIVE COMMITTEE'S APPROVAL FOR CEO COMPENSATION IS DOCUMENTED IN AN E-MAIL FROM THE BOARD CHAIR, WHO CHAIRS THE EXECUTIVE COMMITTEE. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION MAKES ITS FORM 990 AND FORM 1023 AVAILABLE FOR PUBLIC INSPECTION AS REQUIRED UNDER SECTION 6104 OF THE INTERNAL REVENUE CODE. IT IS POSTED ON GUIDESTAR.ORG AND OTHER SIMILAR TYPES OF WEBSITES. IN ADDITION, THE FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY, ARTICLES OF INCORPORATION AND BY-LAWS ARE ALSO AVAILABLE UPON WRITTEN REQUEST OR BY CALLING THE ORGANIZATION DIRECTLY. |
| FORM 990, PART XII, LINE 2C: | THE ORGANIZATION'S AUDIT AND COMPLIANCE COMMITTEE ASSUMES RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF ITS INDEPENDENT AUDITORS. THE POLICY FOR SELECTION AND OVERSIGHT OF THE INDEPENDENT AUDITORS HAS NOT CHANGED SINCE LAST YEAR. |
| Software ID: | |
| Software Version: |